<DOC>
	<DOCNO>NCT02226068</DOCNO>
	<brief_summary>Severe atopic dermatitis ( AD ) recurrent debilitate disease often require systemic immunosuppressive treatment . The efficacy cyclosporine A ( CsA ) well proven potential side effect concern . Several report point extracorporeal photopheresis ( ECP ) efficient alternative treatment modality mild side effect . However , direct comparison CsA ECP treatment AD perform far . In trial test hypothesis ECP non-inferior standard treatment CsA .</brief_summary>
	<brief_title>Photophoresis Versus Ciclosporine Severe Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Criteria inclusion refractoriness standard topical treatment ( corticosteroid ointment , UVA , UVB , PUVA , tar ) . Criteria exclusion pregnancy , uncontrolled hypertension , previous malignancy , infectious disease , liver/kidney disease active treatment ECP immunosuppressant within 4 week prior start trial .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Ciclosporine</keyword>
	<keyword>Extracorporal photopheresis</keyword>
</DOC>